作者
William Kevin Kelly, Susan Halabi, Michael Carducci, Daniel George, John F Mahoney, Walter M Stadler, Michael Morris, Philip Kantoff, J Paul Monk, Ellen Kaplan, Nicholas J Vogelzang, Eric J Small
发表日期
2012/5/5
期刊
Journal of Clinical Oncology
卷号
30
期号
13
页码范围
1534
出版商
American Society of Clinical Oncology
简介
Purpose
A randomized, placebo-controlled study based on preclinical and clinical data that supports the potential role of vascular endothelial growth factor in prostate cancer was performed to evaluate the addition of bevacizumab to standard docetaxel and prednisone therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).
学术搜索中的文章
WK Kelly, S Halabi, M Carducci, D George… - Journal of Clinical Oncology, 2012